Induction of a Pathological Complete Response by Four Courses of Neoadjuvant Chemotherapy for Gastric Cancer: Early Results of the Randomized Phase II COMPASS Trial

Author： Yoshikawa Takaki   Tanabe Kazuaki   Nishikawa Kazuhiro   Ito Yuichi   Matsui Takanori   Kimura Yutaka   Hirabayashi Naoki   Mikata Shoki   Iwahashi Makoto   Fukushima Ryoji   Takiguchi Nobuhiro   Miyashiro Isao   Morita Satoshi   Miyashita Yumi   Tsuburaya Aakira   Sakamoto Junichi  

Publisher： Springer Publishing Company

ISSN： 1068-9265

Source： Annals of Surgical Oncology, Vol.21, Iss.1, 2014-01, pp. : 213-219

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Effect of adding gefitinib to neoadjuvant chemotherapy in estrogen receptor negative early breast cancer in a randomized phase II trial

By Bernsdorf Mogens  

Breast Cancer Research and Treatment, Vol. 126, Iss. 2, 2011-04 ,pp. : 463-470

Springer Publishing Company

Access to resources Recommend Favorite

Predictors of pathological complete response to neoadjuvant chemotherapy in stage II and III breast cancer: The impact of chemotherapeutic regimen

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 5, 2015-01 ,pp. : 1117-1122

Science Publishers

Access to resources Recommend Favorite

Pathological complete response in breast cancer patients following neoadjuvant chemotherapy at a Comprehensive Cancer Center: The natural history of an elusive prognosticator

By        

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 775-780

Science Publishers

Access to resources Recommend Favorite

Prognostic significance of pathological complete response following neoadjuvant chemotherapy for operable breast cancer

By                

Oncology Letters, Vol. 7, Iss. 3, 2014-01 ,pp. : 663-668

Spandidos Publications

Access to resources Recommend Favorite

Analysis of complete response by MRI following neoadjuvant chemotherapy predicts pathological tumor responses differently for molecular subtypes of breast cancer

By                            

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 83-89

Spandidos Publications

Access to resources Recommend Favorite